Business Wire Feed
Molina Healthcare Announces First Quarter 2026 Earnings Release and Conferences Call Dates and Investor Day Meeting
LONG BEACH, Calif.--(BUSINESS WIRE)--Molina Healthcare, Inc. (NYSE: MOH) (“Molina” or the “Company”) today announced it will issue its earnings release for the first quarter ending March 31, 2026, after the market closes on Wednesday, April more...
SelectQuote Announces Participation in Upcoming Mizuho Virtual Healthcare Technology Conference on March 5
OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT), a leading distributor of Medicare insurance policies and owner of a rapidly growing Healthcare Services platform, announced today that Tim Danker, Chief Executive Officer, and Ryan Clement, Chief more...
Humana Inc. to Present at the 2026 Leerink Partners Global Healthcare Conference
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Jim Rechtin, President and Chief Executive Officer, and Celeste Mellet, Chief Financial Officer, will make a presentation to investors at the Leerink Partners Global Healthcare Conference more...
Rockwell Medical to Release Fourth Quarter and Full-Year 2025 Results on Thursday, March 26, 2026
WIXOM, Mich.--(BUSINESS WIRE)--$RMTI #EndStageKidneyDisease--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its more...
PACS Group Intends to Release Fiscal Year and Fourth Quarter 2025 Earnings on February 26, 2026
SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, today announced that it intends to more...
Nearly 75% of Healthcare Organizations Breached Through Email in 2025 Lacked Basic Authentication Protections, Paubox Report Finds
Analysis of breached organizations reveals missing or misconfigured basic email security controls.SAN FRANCISCO--(BUSINESS WIRE)--#PHI--Of the 170 email-related healthcare breaches that were reported to the HHS in 2025, nearly three quarters had no effective policy to more...
MedeAnalytics to Spotlight Healthcare Performance Innovation at HIMSS 2026 With Dual Speaking Sessions
Focus on “how-to” operationalize intelligence to drive ROI that improves performanceRICHARDSON, Texas--(BUSINESS WIRE)--#HIMSS--MedeAnalytics, the healthcare performance improvement company, today announced its participation at the HIMSS Global Health Conference & Exhibition, taking place March 9–12, 2026 more...
FDA Approves NUMELVI™ (atinvicitinib tablets) for Dogs from Merck Animal Health – The First and Only Second-Generation Janus Kinase (JAK) Inhibitor for the Control of Pruritus Associated with Allergic Dermatitis
The only JAK inhibitor approved in the U.S. for the control of pruritus associated with allergic dermatitis in dogs six months of age and olderRAHWAY, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside more...
FIGS Announces Participation in the Raymond James 47th Annual Institutional Investors Conference
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced that Trina Spear, Chief Executive Officer and Co-Founder, and Sarah Oughtred, Chief more...
AdaptHealth Corp. to Participate in Upcoming Investor Conferences
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the more...
TriSalus Life Sciences to Host Fourth Quarter 2025 Financial Results Conference Call
Conference Call and Webcast Scheduled for Thursday, March 5, 2026 at 4:30 PMWESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology-focused medical technology company advancing novel drug delivery technologies alongside more...
Healthcare Litigation Attorney Erin Secord Joins Dorsey in Minneapolis
MINNEAPOLIS--(BUSINESS WIRE)--Erin Secord has joined Dorsey & Whitney LLP as Of Counsel in the Firm’s Healthcare Litigation group in Minneapolis, the international law firm announced today. Erin comes to Dorsey from the U.S. Attorney’s Office, more...
ViiV Healthcare reports positive 12-month data showing investigational bNAb lotivibart (N6LS) maintains high levels of viral suppression in long-acting HIV treatment regimen
94% of adults on stable therapy maintained viral suppression with intravenous lotivibart dosed every four months in combination with long-acting cabotegravir These phase IIb results reinforce lotivibart’s ultra long-acting potential, with the trial progressing to more...
Pure Earth Awarded Funding Through The Audacious Project to Protect Over 500 Million Children from Lead Poisoning by 2033
NEW YORK--(BUSINESS WIRE)--#AudaciousProject--Pure Earth announced today that it has been named an Audacious Project grantee, receiving a major multi-year investment to help governments in more than 20 countries reduce childhood lead poisoning at scale and more...
Mevion Medical Systems Announces CE Marking of the MEVION S250-FIT™ Proton Therapy System, Expanding Global Access to Compact Proton Therapy
CE Marking enables marketing and clinical use of the world’s first and only LINAC vault-ready proton therapy system across the European UnionLITTLETON, Mass.--(BUSINESS WIRE)--#MevionFIT--Mevion Medical Systems, the global leader in compact proton therapy, today announced more...
PureTech to Present at the Leerink Partners Global Healthcare Conference
BOSTON--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, today announced that Robert Lyne, Chief Executive Officer, more...
Azafaros Announces Publication of Preclinical Efficacy Data with Nizubaglustat in GM2 Gangliosidosis
Preclinical proof-of-concept data in GM2 gangliosidosis demonstrated survival benefit, functional improvement and target engagement Results are published in the 7 January issue of the Journal of Inherited Metabolic Disease Nizubaglustat is currently in Phase 3 more...
Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of Injectable Aesthetics
Regulatory authorities in the European Union (EU), the United States (U.S.), and Canada have approved a new state-of-the-art Restylane® syringe for use with a range of Restylane NASHA® lidocaine products in multiple indications in the more...
HekaBio and Alpha Tau Medical Obtain Approval in Japan for Solid Tumor Treatment Alpha DaRT
Offering a New Option for Head and Neck Cancer TreatmentTOKYO--(BUSINESS WIRE)--#cancer--HekaBio K.K., (Headquarters: Chuo-ku, Tokyo) announces that the innovative solid tumor treatment device ‘Alpha DaRT (Diffusing Alpha Radiation Therapy),’ developed by Alpha Tau Medical Ltd. more...
Paysign to Host Fourth Quarter and Full Year 2025 Earnings Call
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, will discuss fourth quarter and full more...
LTC Reports 2025 Fourth Quarter Results and Introduces 2026 Guidance
-- SHOP Momentum Powers Portfolio Transformation with 60% revenue and 13% Core FFO growth –WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--$LTC #LTC--LTC Properties, Inc. (NYSE: LTC) (“LTC” or the “Company”), a real estate investment trust that primarily invests more...
ATEC Reports Fourth Quarter and Full-Year 2025 Financial Results
Full-year 2025 total revenue grew 25% to $764 million, enabling significant profit margin expansion Full-year 2026 total revenue expected to approximate $890 million CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative more...
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in March
- Presentations to be webcast on www.exelixis.com -ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced that company management will participate in fireside chats at the following investor conferences in March: TD Cowen 46th Annual Health more...
Organigram Further Expands Global Portfolio with Launch of Edison and BOXHOT Medical Vapes and Pastilles in Australia
Launch aligns with rising Australian demand for alternatives to flower and strengthens Organigram’s global medical cannabis presenceTORONTO--(BUSINESS WIRE)--Organigram Global Inc. (“Organigram” or the “Company”) today announced the expansion of its international product portfolio, with the more...
Successful Readout of Prospective Phase 2 SINERGY Trial Supports SignateraTM MRD-Guided Treatment in Head and Neck Cancer
Interventional trial validates adaptive Signatera-guided treatment approach, achieving strong 63% response rate while reducing chemotherapy exposure in 74% of patients Results selected for oral plenary at 2026 Multidisciplinary Head and Neck Cancers Symposium (MHNCS)AUSTIN, Texas--(BUSINESS more...